| Active substance | Nintedanib |
| Holder | SCS Boehringer Ingelheim |
| Status | Closed |
| Indication | Idiopathic pulmonary fibrosis (IPF) in adult patients |
| Public documents | Initial approbation |
| Appobation of the amendment | |
| Information for the patient | |
| Informed consent | |
| Last update | 15/12/2017 |
Ofev®
Last updated on 13/09/2024